Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

A Blueprint for Early-Stage Success Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Building on its 50-year history of saving and enhancing lives through the healing power of human cells and tissue, BioBridge Global announced today that it is consolidating its end-to-end Cell and Gene Therapy Services portfolio into a new, highly integrated and coordinated operating subsidiary, BBG Advanced Therapies.

BioBridge Global’s R&D Analytical Development team now has a specialized lab to call their own. 

BioBridge Global CEO Martin Landon spoke on a panel during the Invest San Antonio 2023-2024 Conference on Thursday, noting the organization’s growing capabilities.

South Texas Blood & Tissue leaders were featured in a webinar on an innovative program to collect whole blood-derived platelets. Audra Taylor (VP, Blood Operations)

BioBridge Global celebrated another major advanced therapies milestone March 1, opening its first stand-alone Cell Therapy Testing Laboratory.